CClinicalTrials.gg
RecruitingNCT06655675Updated Jul 11, 2025

Changes in Velocimetric Indices of Uterine and Umbilical Arteries Before and After Combined Spinal-epidural Analgesia in Laboring Women (PART II)

An interventional study of Ultrasound in Labor Pain, sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Recruiting at 1 site in Canada. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-11.

Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Jan 2026, 9 months ago, but the record still lists the study as recruiting.
  • Started Oct 2024; still recruiting 1 year 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Non-randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

Combined spinal-epidural (CSE) for labor analgesia has been used for many years and is practiced commonly at our institution, especially when the patient requests immediate pain relief. CSE is not only beneficial for its faster onset of analgesia, but also it is favorable in relation to the need for rescue analgesia, urinary retention, and rate of instrumental delivery compared to the traditional epidural. Despite its beneficial effects, there is a risk of about 15-30% of developing abnormal fetal heart rate following CSE. This is self-resolving with minimal or no intervention. Although the cause of fetal bradycardia is not fully elucidated, variations in uterine artery blood flow after epidural analgesia are thought to be due to the interaction of numerous events related to blockade of sympathetic innervations, fluid administration, maternal hypotension, uterine vascular effects of sympathetic block, fluctuations in circulating catecholamines, and possibly the effect of opioids. Similar mechanism is thought to be a cause of fetal bradycardia after the CSE with its faster onset and superior block.

Maternal or fetal circulation during labor can be assessed using continuous-wave Doppler ultrasound to monitor maternal uterine artery (UtA) and fetal umbilical artery (UmA) velocity waveforms to detect changes in blood flow. The velocimetry indices mentioned above have been often used to assess the changes in the blood flow before and after the induction of epidural analgesia during labor in several studies. Although there are some studies regarding the effect of labor epidural analgesia using velocimetry indices, but there is currently no published study evaluating velocimetry indices of uterine and umbilical arteries before and after the induction of CSE. Thus, the aim of this study is to investigate the impact of CSE to maternal and fetal blood flow to evaluate the relationships.

The investigators hypothesize that both uterine artery and umbilical artery blood flow are reduced after the induction of CSE, which may be responsible for the occurrence of fetal bradycardia.

02

Conditions studied

  • Labor Pain

Keywords

  • combined spinal epidural (CSE)
  • fetal bradycardia
  • ultrasound
  • velocimetric index
  • hypertension
03

In context

Labor Pain

396 studies on the registry are indexed under Labor Pain; 66 are open to participants now.

This study's planned enrollment of 54 is below the median of 100 across 326 interventional studies indexed under Labor Pain.

Browse Labor Pain studies →

Lead sponsor

Samuel Lunenfeld Research Institute, Mount Sinai Hospital is the lead sponsor of 135 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Written informed consent
  • Term pregnant patients requesting labor analgesia
  • Singleton pregnancy
  • Term pregnant patients in active labor
  • ASA\<4
  • No evidence of fetal congenital anomalies, fetal compromise or fetal decelerations prior to CSE
  • Patients with and without diagnosed hypertensive disorders of pregnancy

Exclusion criteria

Exclusion Criteria:

  • Refusal to consent for the study
  • Known spinal deformities
  • Previous back instrumentation
  • Patients with BMI>50 kg/㎡ due to anticipated technical challenges in Doppler studies
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
54 participants (estimated)

Study arms

  • Experimental
    Ultrasound - patients without hypertensive disorders of pregnancy

    Ultrasound will be used to measure velocimetric index of the umbilical artery.

    Device: Ultrasound

  • Experimental
    Ultrasound - patients with diagnosed hypertensive disorders of pregnancy

    Ultrasound will be used to measure velocimetric index of the umbilical artery.

    Device: Ultrasound

Interventions

  • DeviceUltrasound

    Ultrasound scan of the umbilical artery

06

What researchers measure

Primary outcomes

  1. Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at 10 minutes

    Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured 10 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 10 minutes

  2. Umbilical artery velocimetric index - pulsatility index (PI) at 10 minutes

    Umbilical artery velocimetric index - pulsatility index (PI) will be measured 10 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 10 minutes

  3. Umbilical artery velocimetric index - resistance index (RI) at 10 minutes

    Umbilical artery velocimetric index - resistance index (RI) will be measured 10 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 10 minutes

Secondary outcomes

  1. Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at baseline

    Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured prior to combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 5 minutes

  2. Umbilical artery velocimetric index - pulsatility index (PI) at baseline

    Umbilical artery velocimetric index - pulsatility index (PI) will be measured prior to combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 5 minutes

  3. Umbilical artery velocimetric index - resistance index (RI) at baseline

    Umbilical artery velocimetric index - resistance index (RI) will be measured prior to combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 5 minutes

  4. Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at 5 minutes

    Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured 5 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 5 minutes

  5. Umbilical artery velocimetric index - pulsatility index (PI) at 5 minutes

    Umbilical artery velocimetric index - pulsatility index (PI)will be measured 5 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 5 minutes

  6. Umbilical artery velocimetric index - resistance index (RI) at 5 minutes

    Umbilical artery velocimetric index - resistance index (RI) will be measured 5 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 5 minutes

  7. Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at 20 minutes

    Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured 20 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 20 minutes

  8. Umbilical artery velocimetric index - pulsatility index (PI) at 20 minutes

    Umbilical artery velocimetric index - pulsatility index (PI) will be measured 20 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 20 minutes

  9. Umbilical artery velocimetric index - resistance index (RI) at 20 minutes

    Umbilical artery velocimetric index - resistance index (RI) will be measured 20 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 20 minutes

  10. Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at 30 minutes

    Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured 30 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 5 minutes

  11. Umbilical artery velocimetric index - pulsatility index (PI) at 30 minutes

    Umbilical artery velocimetric index - pulsatility index (PI) will be measured 30 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 30 minutes

  12. Umbilical artery velocimetric index - resistance index (RI) at 30 minutes

    Umbilical artery velocimetric index - resistance index (RI) will be measured 30 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 30 minutes

  13. Pain score at baseline - questionnaire

    Pain score - verbal numeric rating scale (0-10) prior to combined spinal epidural

    Time frame: 1 minute

  14. Pain score at 10 minutes - questionnaire

    Pain score - verbal numeric rating scale (0-10) at 10 minute after combined spinal epidural

    Time frame: 10 minutes

  15. Pain score at 30 minutes - questionnaire

    Pain score - verbal numeric rating scale (0-10) at 30 minute3 after combined spinal epidural

    Time frame: 30 minutes

  16. Sensory block level at 10 minutes

    Sensory block level at 10 minutes following combined spinal epidural

    Time frame: 10 minutes

  17. Sensory block level at 30 minutes

    Sensory block level at 30 minutes following combined spinal epidural

    Time frame: 30 minutes

  18. frequency of uterine contractions

    The number of contractions on the monitor in a 10 minute period.

    Time frame: 10 minutes

  19. Presence of prolonged hypertonic uterine contractions- questionnaire

    Presence of prolonged hypertonic uterine contractions as measured by the monitor

    Time frame: 30 minutes

  20. Hypotension: systolic blood pressure less than 80% of baseline

    Systolic blood pressure \< 80% of baseline, monitored q5 for 30 minutes following combined spinal epidural

    Time frame: 30 minutes

  21. Hypertension: systolic blood pressure greater than 120% of baseline

    Systolic blood pressure \> 120% of baseline, monitored q5 for 30 minutes following combined spinal epidural

    Time frame: 30 minutes

  22. Bradycardia: heart rate less than 70% of baseline

    Heart rate \< 70% of baseline or a heart rate \< 50bpm, monitored q5 for 30 minutes following combined spinal epidural

    Time frame: 30 minutes

  23. Desaturation: oxygen level <95%

    Oxygen level \<95%, monitored q5 for 30 minutes following combined spinal epidural

    Time frame: 30 minutes

  24. fetal heart rate at baseline

    fetal heart rate at baseline, prior to combined spinal epidural

    Time frame: 5 minutes

  25. fetal heart rate q5 min up to 30 minutes

    fetal heart rate q5 min up to 30 minutes following combined spinal epidural

    Time frame: 30 minutes

  26. presence of fetal bradycardia - questionnaire

    presence of fetal bradycardia (fetal heart rate \<110)

    Time frame: 30 minutes

  27. presence of fetal prolonged deceleration - questionnaire

    presence of fetal prolonged deceleration (fetal heart rate \<110/min lasting less than 10 minutes)

    Time frame: 30 minutes

  28. presence of fetal persistent late decelerations - questionnaire

    presence of fetal persistent late decelerations will be recorded

    Time frame: 30 minutes

  29. presence of fetal non-reassuring variable deceleration - questionnaire

    presence of fetal non-reassuring variable deceleration will be recorded

    Time frame: 30 minutes

  30. presence of fetal salutatory variability - questionnaire

    presence of fetal salutatory variability (FHR change\>25beats) will be recorded

    Time frame: 30 minutes

  31. Neonatal weight

    Neonatal weight measured after delivery in grams minutes

    Time frame: up to 24 hours

  32. Apgar score at 1 minute

    Apgar score at 1 minute

    Time frame: 1 minute

  33. Apgar score at 5 minutes

    Apgar score at 5 minutes

    Time frame: 5 minutes

  34. Mode of delivery - questionnaire

    Mode of delivery will be recorded as vaginal, assisted (forceps or vacuum), or cesarean

    Time frame: up to 24 hours

07

Study locations

1 of 1 sites recruiting
  • Mount Sinai Hospital
    Toronto, Ontario M5G1X5, Canada
    • Mrinalini Balki, MD · Contact · mrinalini.balki@uhn.ca · 416-586-4800
    • Javiera Vargas Zuniga, MD · Sub investigator
    • Fernanda Lanza Oliveira, MD · Sub investigator
    • Claudia Jimenez, MD · Sub investigator
    • Amir Siddiqui, MD · Sub investigator
    • Cristian Arzola, MD · Sub investigator
    • Kristi Downey, MSc · Sub investigator
    • Sebastian Hobson, MD · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06655675
Lead sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Responsible party
Sponsor
First posted
Oct 23, 2024
Start date
Oct 30, 2024
Primary completion
Jan 2026 (estimated)
Completion
Jan 2026 (estimated)
Last update
Jul 11, 2025

Study contacts

Mrinalini Balki, MD
Contact
mrinalini.balki@uhn.ca
416-586-4800 ext. 5270
Mrinalini Balki, MD
principal investigator · MOUNT SINAI HOSPITAL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion